Imperial Capital Raises Price Target on Proofpoint (PFPT) to $83 Following 2Q Beat

Unusual 11 Mid-Day Movers 7/22: (CADC) (CLNT) (PBYI) Higher; (QUMU) (BAS) (MCF) Lower

China Advanced Construction Materials (Nasdaq: CADC) 34.5% HIGHER; ripping higher from the start on Friday with heavy volume.

Cleantech Solutions (Nasdaq: CLNT) 32.7% HIGHER; On July 18, 2016, the Company entered into a stock purchase agreement pursuant to which the Company sold 260,000 shares of common stock at a purchase price of $1.04 per share. The shares were sold pursuant to a prospectus supplement dated July 18, 2016 to the Companys registration statement on Form S-3, File No. 333-188142. The Company did not... More

Pre-Open Stock Movers 07/22: (PBYI) (EYES) (PFPT) (AMD) Higher; (OPTT) (OLN) (SKX) Lower (more...)

Today's Pre-Open Stock Movers

Puma Biotechnology, Inc. (NYSE: PBYI) 19.8% HIGHER; submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate PB272 (neratinib) for the extended adjuvant treatment of patients with early stage HER2-overexpressed/amplified breast cancer who have received prior adjuvant trastuzumab (Herceptin®)-based therapy. Also, announced updated results from the Phase III clinical trial of Pumas investigational drug PB272 (neratinib) for the extended adjuvant treatment of... More

Proofpoint (PFPT): Second Best Quarter Ever - Piper Jaffray

Piper Jaffray analyst, Andrew Nowinski, reiterated his Overweight rating on shares of Proofpoint (NASDAQ: PFPT) with a price target of $85.00. Proofpoint reported the second best quarter in company history, exceeding the high end of guidance by 6.4% and reported earnings profitability two quarters earlier than expected.... More

Pacific Crest Downgrades Proofpoint (PFPT) to Sector Weight

Pacific Crest downgraded Proofpoint (NASDAQ: PFPT) from Overweight to Sector Weight. Analyst Rob Owens doesn't recommend purchasing shares at current levels.

"Consistent with checks, Proofpoint had stronger-than-expected results, topping all of our quarterly expectations. But as PFPT shares have meaningfully "squeezed"... More